VEDOLIZUMAB DEMONSTRATES EARLY SYMPTOMATIC IMPROVEMENT IN ULCERATIVE COLITIS: A GEMINI 1 POST HOC ANALYSIS
Brian G. Feagan 1
Karen Lasch 2
Javaria Mona Khalid 3
Charlie Cao 2
Abigail M Wojtowicz 2
Alexandra James
Jean-Frederic Colombel
1 Robarts Research Institute, University of Western Ontario,London,Canada
2 Takeda Pharmaceuticals USA, Inc.,Deerfield,United States of America
3 Takeda Development Centre Europe,London,United Kingdom
Conference
25th UEG Week 2017
Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing